Amedeo's Top 20

Amedeo Smart

Independent Medical Education


15 April 2024

Multidisciplinary Journal Club

  1. Calabrese M, Preziosa P, Scalfari A, Colato E, et al.
    Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis.
    Ann Neurol 2024.

  1. Tapper EB, Warner MA, Shah RP, Emamaullee J, et al.
    Management of coagulopathy among patients with cirrhosis undergoing upper endoscopy and paracentesis: Persistent gaps and areas of consensus in a multispecialty Delphi.
    Hepatology 2024.

  2. Villagelin D, Cooper DS, Burch HB.
    A 2023 International Survey of Clinical Practice Patterns in the Management of Graves' Disease: A Decade of Change.
    J Clin Endocrinol Metab 2024.

  3. Wong K, Pitcher D, Braddon F, Downward L, et al.
    Effects of rare kidney diseases on kidney failure: a longitudinal analysis of the UK National Registry of Rare Kidney Diseases (RaDaR) cohort.
    Lancet 2024;403:1279-1289.

  4. Schwarz ES.
    Low-dose ketamine safely reduces acute pain in the ED with a more rapid and shorter effect than morphine.
    Ann Intern Med 2024.

  1. Kendler KS, Abrahamsson L, Sundquist J, Sundquist K, et al.
    Pattern of Risks for Psychiatric and Substance Use Disorders in the Offspring of Parents With Alcohol Use Disorder.
    Am J Psychiatry 2024;181:322-329.

  2. Johansson K, Bodnar LM, Stephansson O, Abrams B, et al.
    Safety of low weight gain or weight loss in pregnancies with class 1, 2, and 3 obesity: a population-based cohort study.
    Lancet 2024.

  3. Krause AJ, Greytak M, Kaizer AM, Carlson DA, et al.
    Diagnostic Yield of Ambulatory Reflux Monitoring Systems for Evaluation of Chronic Laryngeal Symptoms.
    Am J Gastroenterol 2024;119:627-634.

  4. Tripto-Shkolnik L, Szalat A, Tsvetov G, Rouach V, et al.
    Oral daily PTH(1-34) tablets (EB613) in postmenopausal women with low BMD or osteoporosis: a randomized, placebo-controlled, six-month, phase 2 study.
    J Bone Miner Res 2024.

  5. Stoumpos S, Crowe K, Sarafidis P, Barratt J, et al.
    Hypoxia-inducible factor prolyl hydroxylase inhibitors for anaemia in chronic kidney disease: a document by the European Renal Best Practice board of the European Renal Association.
    Nephrol Dial Transplant 2024.

  1. Shoji J, Goggins WC, Wellen JR, Cunningham PN, et al.
    Efficacy and Safety of Bleselumab in Preventing the Recurrence of Primary Focal Segmental Glomerulosclerosis in Kidney Transplant Recipients: A Phase 2a, Randomized, Multicenter Study.
    Transplantation 2024.

  2. Cerulli Irelli E, Cocchi E, Morano A, Gesche J, et al.
    Predictors of Seizure Recurrence in Women With Idiopathic Generalized Epilepsy Who Switch From Valproate to Another Medication.
    Neurology 2024;102:e209222.

  3. Gielen E, Aldven M, Kanis JA, Borgstrom F, et al.
    Cost-effectiveness of romosozumab for the treatment of postmenopausal women with osteoporosis at high risk of fracture in Belgium.
    Osteoporos Int 2024.

  4. Roy S, Fervaha G, Spratt DE, Sun Y, et al.
    Prostate Radiotherapy in Low-volume Metastatic Hormone-sensitive Prostate Cancer: A Network Meta-analysis.
    Eur Urol 2024.

  5. Rodriguez EE, Zaccarelli M, Sterchele ED, Taccone FS, et al.
    "NeuroVanguard": a contemporary strategy in neuromonitoring for severe adult brain injury patients.
    Crit Care 2024;28:104.

  1. Chanan EL, Wagener G, Whitlock EL, Berger JC, et al.
    Perioperative Considerations in Older Kidney and Liver Transplant Recipients: A Review.
    Transplantation 2024.

  2. Gausi K, Ignatius EH, De Jager V, Upton C, et al.
    High-Dose Isoniazid Lacks EARLY Bactericidal Activity Against Isoniazid-resistant Tuberculosis Mediated by katG Mutations: A Randomized, Phase 2 Clinical Trial.
    Am J Respir Crit Care Med 2024.

  3. Phillips K, Nirantharakumar K, Wakerley BR, Crowe FL, et al.
    Trends in the prevalence and pharmacological management of migraine during pregnancy in the UK, 2000-2018.
    J Neurol Neurosurg Psychiatry 2024.

  4. Franco-Rubio L, Puente-Martinez A, Ubillos-Landa S.
    Factors associated with recovery during schizophrenia and related disorders: A review of meta-analysis.
    Schizophr Res 2024;267:201-212.

  5. Englman C, Maffei D, Allen C, Kirkham A, et al.
    PRECISE Version 2: Updated Recommendations for Reporting Prostate Magnetic Resonance Imaging in Patients on Active Surveillance for Prostate Cancer.
    Eur Urol 2024.


more..


Privacy Policy